Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115851694A details a novel immobilized enzyme method for synthesizing 2'-fluoro-deoxyribonucleosides, offering superior stability, reusability, and cost-effective manufacturing for antiviral intermediates.
Patent CN114891049A reveals a stable glycosylation method enabling rapid oligosaccharide synthesis with high yields and simplified purification for reliable pharmaceutical intermediates supplier.
Novel Au(I)-catalyzed glycosylation for high-purity Etoposide. Enhanced selectivity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel Pummerer reaction method for sulfur-containing aryl carbon glycosides. Mild conditions, high yield, suitable for API intermediate manufacturing.
Novel stable glycosylation donor technology enabling mild conditions and orthogonal protection for high-purity pharmaceutical intermediates manufacturing.
Patent CN111100172B reveals a mild Lewis acid catalyzed route for high-purity capecitabine intermediates, offering significant cost and supply chain advantages.
Patent CN106589015A reveals optimized Tribenoside synthesis reducing waste and improving purity. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN112028947B reveals a novel alkaline synthesis for Tribenoside, eliminating genotoxic impurities and ensuring high purity for reliable pharmaceutical intermediate supply chains.
Novel synthesis route for empagliflozin intermediates offering high purity and cost reduction in pharma manufacturing. Reliable supply chain for diabetes drug precursors ensures continuity.
Patent CN102924548A details a safer Capecitabine synthesis using Lewis acids instead of toxic tin, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108929348A reveals optimized IPTG synthesis yielding over 85 percent. This method reduces costs and improves supply chain reliability for biochemical research intermediates globally.
Patent CN103360439A details a novel synthesis route for Fondaparinux Sodium, offering improved purification and industrial scalability for anticoagulant manufacturing.
Patent CN104592321A details a high-yield catalytic route for Salidroside. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Novel two-step stereocontrolled synthesis of ADP-ribose polypeptides from NAD. Reduces purification complexity and enables scalable production for drug discovery.
Novel scalable route for antisense oligonucleotide intermediates ensuring high purity and cost reduction without preparative chromatography.
Patent CN110818750B reveals a convergent route to high-purity Stevioside R using gold catalysis, offering cost reduction and supply reliability for food additive manufacturing.
Patent CN120554343A reveals new iron and palladium catalytic route. Improves yield and safety for empagliflozin manufacturing supply chain.
Patent CN103694285B reveals a two-step IPTG synthesis method improving yield and reducing cost for high-purity biochemical intermediate manufacturing supply chains.
Patent CN103694285B reveals a two-step IPTG synthesis improving yield and reducing costs for pharmaceutical intermediates manufacturing supply chains.